|
Product name
|
Product type
|
Date released
|
| |
SYMTUZA is a single tablet regiment used to treat adults and adolescents 12 years
of age and older who weigh at least 40 kg, who are infected by HIV (Human Immunodeficiency
Virus).
SYMTUZA contains four active ingredients which work in combination for the treatment
of HIV. These active ingredients are darunavir, cobicistat, emtricitabine and tenofovir
alafenamide.
Darunavir, emtricitabine and tenofovir alafenamide are called antiretroviral medicines.
Darunavir is medicine known as a protease inhibitor. Emtricitabine is a medicine known
as a nucleoside reverse transcriptase inhibitor. Tenofovir alafenamide is a medicine
known as a nucleotide reverse transcriptase inhibitor. Each of these three active
ingredients work to reduce the amount of HIV in your body.
Cobicistat is a type of medicine called a pharmacokinetic enhancer (or "booster").
Cobicistat helps to increase the levels of darunavir in your body.
Reducing the amount of HIV in your blood improves your immune system and reduces the
risk of developing illnesses as a result of HIV infection.
Ask your doctor if you have any questions about why SYMTUZA has been prescribed for
you.
This medicine is available only with a doctor's prescription.
read more
|
|
| |
UPTRAVI contains the active substance selexipag. It is a medicine that acts on a receptor
that is the target of a natural substance called "prostacyclin".
UPTRAVI is used for the long-term treatment of pulmonary arterial hypertension (PAH)
in adults.
It can be used on its own or with other medicines for PAH. PAH is high blood pressure
in the blood vessels that carry blood from the heart to the lungs (the pulmonary arteries).
In people with PAH, these arteries narrow, so the heart has to work harder to pump
blood through them. This may cause people to feel tired, dizzy, short of breath, or
experience other symptoms.
UPTRAVI widens the pulmonary arteries and reduces their hardening. This makes it easier
for the heart to pump blood through the pulmonary arteries. It relieves the symptoms
of PAH and improves the course of the disease.
Your doctor however, may prescribe UPTRAVI for another purpose.
Ask your doctor if you have any questions about why it has been prescribed for you.
read more
|
|
| |
Do not use if you have ever had an allergic reaction to citalopram or any of the ingredients
listed at the end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines,
or are pregnant or plan to become pregnant or are breastfeeding.
read more
|
|
|
|
| |
NUCALA is a medicine which contains the active substance mepolizumab, a monoclonal
antibody. This antibody blocks a specific protein called interleukin-5. By blocking
the action of interleukin-5, NUCALA limits the production of more eosinophils (a type
of white blood cell) from the bone marrow and lowers the number of eosinophils in
the bloodstream and the lungs.
NUCALA is used to treat severe eosinophilic asthma, chronic rhinosinusitis with nasal
polyps or eosinophilic granulomatosis with polyangiitis (EGPA).
Severe eosinophilic asthma
Some people with severe asthma have too many eosinophils (a type of white blood cell)
in the blood, lungs and tissues. Having too many eosinophils in your blood can damage
the airways and can cause your asthma to get worse or can increase the number of your
asthma flare ups.
NUCALA is used to treat asthma by reducing the frequency of asthma flare ups in adolescents
(over 12 years of age) and adults who are already receiving asthma medicines, but
whose asthma flare ups are not well controlled by medicines such as high-dose corticosteroid
inhalers or beta-agonist inhalers.
NUCALA can also be used to help reduce the daily dose of oral corticosteroids in patients
taking these medicines to control asthma symptoms and flare ups.
NUCALA does not treat acute asthma symptoms, such as a sudden asthma attack. Therefore,
NUCALA should not be used to treat such symptoms.
Chronic rhinosinusitis with nasal polyps
Chronic rhinosinusitis with nasal polyps is a condition in which people have too many
eosinophils in the blood, nose and sinuses. This can cause symptoms such as a blocked
nose and loss of smell, and soft jelly-like growths (called nasal polyps) to form
inside the nose.
NUCALA reduces the number of eosinophils in the blood and in adults (18 years and
above) can reduce the size of your polyps, relieve your nasal congestion and helps
prevent surgery for nasal polyps.
NUCALA can also help reduce the need for oral corticosteroids to control your symptoms.
Eosinophilic Granulomatosis with Polyangiitis (EGPA)
EGPA is a condition where people have too many eosinophils in the blood and tissues,
and also have inflammation of the blood vessels (vasculitis). EGPA most commonly affects
the lungs and sinuses but often affects other organs including the skin, heart, kidneys,
nerves or bowels.
NUCALA can reduce symptoms and delay a flare-up of these symptoms in people who are
already taking corticosteroids.
NUCALA can also help reduce the daily dose of corticosteroids you need to control
your symptoms.
Ask your doctor if you have any questions about why this medicine has been prescribed
for you.
This medicine is available only with a doctor's prescription.
read more
|
|
| |
NUCALA is a medicine which contains the active substance mepolizumab, a monoclonal
antibody. This antibody blocks a specific protein called interleukin-5. By blocking
the action of interleukin-5, NUCALA limits the production of more eosinophils (a type
of white blood cell) from the bone marrow and lowers the number of eosinophils in
the bloodstream and the lungs.
NUCALA is used to treat severe eosinophilic asthma, chronic rhinosinusitis with nasal
polyps and eosinophilic granulomatosis with polyangiitis (EGPA).
Severe eosinophilic asthma
Some people with severe asthma have too many eosinophils (a type of white blood cell)
in the blood, lungs and tissues. Having too many eosinophils in your blood can damage
the airways and can cause your asthma to get worse or can increase the number of your
asthma flare ups.
NUCALA is used to treat asthma by reducing the frequency of asthma flare ups in adolescents
(over 12 years of age) and adults who are already receiving asthma medicines, but
whose asthma flare ups are not well controlled by medicines such as high-dose corticosteroid
inhalers or beta-agonist inhalers.
NUCALA can also be used to help reduce the daily dose of oral corticosteroids in patients
taking these medicines to control asthma symptoms and flare ups.
NUCALA does not treat acute asthma symptoms, such as a sudden asthma attack. Therefore,
NUCALA should not be used to treat such symptoms.
Chronic rhinosinusitis with nasal polyps
Chronic rhinosinusitis with nasal polyps is a condition in which people have too many
eosinophils in the blood, nose and sinuses. This can cause symptoms such as a blocked
nose and loss of smell, and soft jelly-like growths (called nasal polyps) to form
inside the nose.
NUCALA reduces the number of eosinophils in the blood and in adults (18 years and
above) can reduce the size of your polyps, relieve your nasal congestion and helps
prevent surgery for nasal polyps.
NUCALA can also help reduce the need for oral corticosteroids to control your symptoms.
Eosinophilic Granulomatosis with Polyangiitis (EGPA)
EGPA is a condition where people have too many eosinophils in the blood and tissues,
and also have inflammation of the blood vessels (vasculitis). EGPA most commonly affects
the lungs and sinuses but often affects other organs including the skin, heart, kidneys,
nerves or bowels.
NUCALA can reduce symptoms and delay a flare-up of these symptoms in people who are
already taking corticosteroids.
NUCALA can also help reduce the daily dose of corticosteroids you need to control
your symptoms.
Ask your doctor if you have any questions about why this medicine has been prescribed
for you.
This medicine is available only with a doctor's prescription.
read more
|
|
|
|
| |
Do not use if you have ever had an allergic reaction to Adacel or any of the ingredients
listed at the end of the CMI.
Talk to your doctor if you have any other medical conditions, take any other medicines,
or are pregnant or plan to become pregnant or are breastfeeding.
read more
|
|
| |
Fasturtec contains rasburicase rys, which is a recombinant urate-oxidase enzyme. Fasturtec
is used to prevent or to decrease the high levels of uric acid in your blood that
can occur as a result of chemotherapy for cancers of the blood, such as leukemia or
lymphoma. Normal amounts of uric acid in the blood are removed by the kidneys. If
there are high levels of uric acid in the blood, your kidneys may not be able to remove
the excess, and may be damaged. Fasturtec converts uric acid into a substance called
allantoin, which is easier for your kidneys to remove.
Your doctor may have prescribed Fasturtec for another reason.
Ask your doctor or pharmacist if you have any questions about why this medicine has
been prescribed for you.
Fasturtec is not addictive.
This medicine is available only with a doctor's prescription.
read more
|
|
|
|
|
|
|
|
|
|
| |
Moxicam is used to treat the symptoms of osteoarthritis and rheumatoid arthritis.
Both of these diseases mainly affect the joints causing pain and swelling.
Although Moxicam can relieve symptoms such as pain and inflammation, it will not cure
your condition.
Moxicam belongs to a family of medicines called Non-Steroidal Anti-inflammatory Drugs
(NSAIDs). These medicines work by relieving pain and inflammation.
Ask your doctor if you have any questions why this medicine has been prescribed for
you.
Your doctor may have prescribed it for another reason.
It is available only with a doctor's prescription.
read more
|
|
|
|
|
|
|
|
|
|
|
|
|
|
